Thank you, Chair.
Thank you to all the witnesses joining us for this important study. We've spoken to many witnesses, and as my colleagues have mentioned, this topic is very sensitive and a lot of them have been very impacted by this.
I'm going to direct these questions to Ms. Garrett-Baird. Hopefully they are for you, and if not, you can redirect me.
You mentioned that the $150 million has not been used as of yet, and obviously the work, it sounds like, is now under way with the report that's been put in front of us. Are you able to share what alternative programs, if any, can be used to distribute the $150 million? Are we at the point where you're formulating or thinking through what we're able to distribute or hoping to distribute?